Advaxis, Inc. Share Price OTC Bulletin Board
Equities
US0076241092
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 692K 54.75M | Sales 2023 | 13K 1.03M | Capitalization | 7.94M 628M |
---|---|---|---|---|---|
Net income 2022 | -38M -3.01B | Net income 2023 | -48M -3.8B | EV / Sales 2022 * | - |
Net cash position 2022 | 657K 51.98M | Net Debt 2023 | 3.43M 272M | EV / Sales 2023 | 875 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Ken Berlin
CEO | Chief Executive Officer | 59 | 22/04/18 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
CHM | Chairman | 64 | 15/07/13 |
Roni Appel
CEO | Chief Executive Officer | 57 | 31/10/04 |
Murray Goldberg
BRD | Director/Board Member | 79 | 18/01/23 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |